Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

A prospective pilot trial of the health data monitoring system without educational content for patients with hypertension

Hypertension Research volume 47, pages 529–532 (2024)Cite this article

A Comment to this article was published on 19 January 2024

Abstract

In Japan, a hypertension treatment aid application (CureApp Co., Ltd.) with educational content on hypertension was the first in the world to show significant blood pressure (BP) reduction in hypertensive patients in 2021. Omron Healthcare Corporation and I developed the Health data Monitoring System (HMS) without educational content, which allows patients to check their home BP values periodically and allows physicians to check their home BP data before the hospital visit. As a pilot study, nineteen patients with hypertension used HMS for six months. The percentage of patients achieving their antihypertensive goal increased from 16% to 37%. Mean home systolic BP decreased from 138.1 ± 11.8 mmHg to 130.2 ± 7.8 mmHg. The increase in number of home BP measurements was significantly associated with the amount of homed systolic BP reduction in men. In conclusion, HMS without educational content may be an adjunct to hypertension treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kario K, Harada N, Okura A. The first software as a medical device of evidence-based hypertension digital therapeutics for clinical practice. Hypertens Res. 2022;45:1899–905.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kario K, Harada N, Okura A. Digital therapeutics in hypertension: evidence and perspectives. Hypertension. 2022;79:2148–58.

    Article  CAS  PubMed  Google Scholar 

  3. Willis M, Darwiche G, Carlsson M, Nilsson A, Wohlin J, Lindgren P. Real-world long-term effects on blood pressure and other cardiovascular risk factors for patients in digital therapeutics. Blood Press Monit. 2023;28:86–95.

    Article  PubMed  Google Scholar 

  4. Kario K, Hoshide S, Mogi M. Digital hypertension 2023: concept, hypothesis, and new technology. Hypertens Res. 2022;45:1529–30.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kario K, Nomura A, Harada N, Tanigawa T, So R, Nakagawa K, et al. A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trial. J Clin Hypertens. 2020;22:1713–22.

    Article  Google Scholar 

  6. Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J. 2021;42:4111–22.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

    Article  PubMed  Google Scholar 

Download references

Funding

This study was financially supported by Omron Healthcare Co. Ltd.

Author information

Authors and Affiliations

  1. Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare, Okawa, Japan

    Takuya Kishi

  2. Omron Heathcare Co., Ltd., Kyoto, Japan

    Hiroshi Usui & Sho Nagayoshi

Authors
  1. Takuya Kishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Usui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sho Nagayoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takuya Kishi.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics

TK received research funding from Omron Healthcare Co. Ltd.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kishi, T., Usui, H. & Nagayoshi, S. A prospective pilot trial of the health data monitoring system without educational content for patients with hypertension. Hypertens Res 47, 529–532 (2024). https://doi.org/10.1038/s41440-023-01510-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01510-9

Keywords

This article is cited by

Search

Advanced search

Quick links